We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Amkor Technology (AMKR - Free Report) is a leading outsourced semiconductor assembly and test service provider (OSAT). The company packages and tests integrated circuits for customers across smartphones, data centers, artificial intelligence (AI), automotive, industrial and consumer devices. Amkor Technology is increasingly positioning advanced packaging as a key growth engine. With semiconductor architectures becoming more complex, packaging is moving closer to the critical path for system performance and value creation. Amkor’s momentum is already evident in its financial performance. Second-quarter 2026 revenues rose 26% year over year, with growth across all end markets, led by advanced packaging demand. Driven by demand for AI data centers, increased production of high-performance CPUs and the continued strong positioning of advanced technology platforms, management projects net sales of $1.95 billion to $2.05 billion for the third quarter of 2026. If these operations expand as anticipated, advanced packaging could become a crucial driver of revenue growth and competitive differentiation for the company. AMKR shares have gained 38.9% year to date
GeneDx Holdings Corp. (WGS - Free Report) is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. Earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and this trend might continue with its still improving earnings outlook. The upward trend in estimate revisions for this company reflects growing optimism of analysts on its earnings prospects, which should get reflected in its stock price. Consensus earnings estimates for the next quarter and full year have moved considerably higher for GeneDx Holdings Corp., as there has been strong agreement among the covering analysts in raising estimates.
View the Zacks #1 Rank List
Top Stock Picks for Week of August 24, 2026
Amkor Technology (AMKR - Free Report) is a leading outsourced semiconductor assembly and test service provider (OSAT). The company packages and tests integrated circuits for customers across smartphones, data centers, artificial intelligence (AI), automotive, industrial and consumer devices. Amkor Technology is increasingly positioning advanced packaging as a key growth engine. With semiconductor architectures becoming more complex, packaging is moving closer to the critical path for system performance and value creation. Amkor’s momentum is already evident in its financial performance. Second-quarter 2026 revenues rose 26% year over year, with growth across all end markets, led by advanced packaging demand. Driven by demand for AI data centers, increased production of high-performance CPUs and the continued strong positioning of advanced technology platforms, management projects net sales of $1.95 billion to $2.05 billion for the third quarter of 2026. If these operations expand as anticipated, advanced packaging could become a crucial driver of revenue growth and competitive differentiation for the company. AMKR shares have gained 38.9% year to date
GeneDx Holdings Corp. (WGS - Free Report) is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. Earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and this trend might continue with its still improving earnings outlook. The upward trend in estimate revisions for this company reflects growing optimism of analysts on its earnings prospects, which should get reflected in its stock price. Consensus earnings estimates for the next quarter and full year have moved considerably higher for GeneDx Holdings Corp., as there has been strong agreement among the covering analysts in raising estimates.